Clinical Trials Logo
  1. Home
  2. Candidiasis, Vulvovaginal
  3. NCT02180828

Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis

Candidiasis, Vulvovaginal Clinical Trial

Official title:
An Case-controlled Randomized Study to the Efficacy of Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis

Clinical Trial Summary

The study is focused to prove that the efficacy and safety of Clotrimazole vaginal tablet vs Fluconazole for the treatment of severe vulvovaginal candidiasis

Clinical Trial Description

The current study is evaluating both the efficacy and safety of the 2 doses of 500 mg clotrimazole vaginal tablet administered intravaginally( at day 1 and day 4) v.s 2 doses of 150 mg fluconazole( at day 1 and day 4) for treatment of severe vulvovaginal candidiasis.The number of participants with adverse events as a measure of safety and tolerability. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02180828
Study type Interventional
Source Peking University Shenzhen Hospital
Contact
Status Completed
Phase Phase 4
Start date July 2014
Completion date September 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT02971007 - Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Phase 2
Completed NCT02251093 - Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis Phase 3
Completed NCT01293643 - A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) Phase 3
Not yet recruiting NCT04626258 - Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis Phase 4
Completed NCT02733432 - RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections Phase 2
Completed NCT02248506 - Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis Phase 4
Completed NCT02730494 - Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation Phase 1
Recruiting NCT04930107 - Vulvovaginal Candidiasis in Canadian Females Early Phase 1
Withdrawn NCT03167957 - Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis Phase 2
Recruiting NCT05367089 - The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms Phase 3
Terminated NCT02859493 - Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis N/A
Completed NCT01891331 - A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) Phase 2
Completed NCT02888197 - Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization N/A
Completed NCT03975569 - Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis N/A
Recruiting NCT05059145 - A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis Phase 2
Recruiting NCT03075046 - Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial N/A